Polymorphisms of the Aldose Reductase gene and susceptibility to retinopathy and nephropathy in Caucasian type 1 diabetes;Polymorphismes du gène de l'aldose réductase et susceptibilité à la reνtinopathie et à la néphropathie chez des caucasiens diabeνtiques de type 1

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 7-8, 2002, Pages 701-708

  Fanelli, A ^a   Hadjadj, S ^b   Gallois, Y ^c   Fumeron, F ^a   Betoule, D ^a   Grandchamp, B ^d   Marre, M ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b University of Poitiers   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; MICROSATELLITE DNA;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS;

ADULT; ALDEHYDE REDUCTASE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 17444451888     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Orchard TJ, Dorman JS, Maser RE et al. Prevalence of complications in IDDM by sex ond duration. Pittsburg Epidemiolgqy of Diabetes Complications Study II. Diabetes 1990; 39: 1116-24.
2. Ko BC, Lam KS, Wat NM, Chung SS. An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the oldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995; 44: 727-32.
3. Kao YL, Donaghue K, Chan A, Knight J, Silink M. A novel polymorphism in the aldose reductose gene promoteur region is strongly associated with diabetic retinopothy in adolescents with type 1 diabetes. Diobetes 1999; 48: 1338-40.
4. Klein R, Klein B, Moss SE, Davis MD, De Mets DL. The Wisconsin epidemiologic study of diabetic retinopothy: II: Prevalence and risk of diabetic when age at diagnosis is less than 30 years. Arch Ophtalmol 1984; 102: 520-6.
5. Heesom AE, Hibberd ML, Millward A, Demaine AG. Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropothy in type I diabetes. Diabetes 1997; 46: 287-91.
6. Moczulski DK, Scott L, Antonellis A et al. Aldose reductose gene polymorphisms and susceptibility to diabetic nephropothy in type 1 diabetes mellitus. Diabete Med 2000; 17: 111-8.
7. Ng PKD, Conn J, Chung SSM, Larkins RG. Aldose Reductase (AC)n microsatellite polymorphism and diabetic microvascular complications in Caucasian type 1 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 21-7.
8. Marre M, Jeunemaitre X, Gallois Y et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diobetes. Génétique de la Néphropathie Diabétique (GENEDIAB) study group. J Clin Invest 1997; 99: 1585-95.
9. Gallois Y, Vol S, Caces E, Balkau B, and the DESIR Study Group. Distribution of fasting serum insulin, meosured by enzymoimmunoassay, in an unsalected population of 4 032 individuals, references volues, occording to oge and sex. Diabetes Metab 1996; 22: 427-31.
10. Hadjadj S, Belloum R, Bouhanick B et al. Prognostic value of angliotensin-1 converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 2001; 12: 541-9.